Navigation Links
Professor Dennis Lo Trisomy 21 Clinical Validation Study Published in British Medical Journal
Date:1/12/2011

SAN DIEGO, Jan. 12, 2011 /PRNewswire/ -- Sequenom (Nasdaq: SQNM) is very pleased to note the publication in the British Medical Journal (BMJ 2011;342:c7401) of a groundbreaking international study led by our longstanding collaborator, Professor Dennis Lo of The Chinese University of Hong Kong. Building on early work from the Lo laboratory, the present paper is the first report of a large-scale clinical study that validates a noninvasive, plasma DNA-based approach for prenatally detecting Down's syndrome (T21). Sequenom congratulates the research team for their achievements.

(Logo: http://photos.prnewswire.com/prnh/20040415/SQNMLOGO)

About Sequenom

Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a Web site at http://www.sequenom.com to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom Web site to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the Web site.

SEQUENOM® is a trademark of Sequenom, Inc. All other trademarks and service marks are the property of their respective owners.

Forward-Looking Statements

Except for the historical information contained herein, the matters set forth in this press release, including statements regarding the Company's commitment to improving healthcare through revolutionary genetic analysis solutions, are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the risks and uncertainties associated with the Company's ability to develop and commercialize new technologies and products, particularly new technologies such as genetic analysis platforms, noninvasive prenatal diagnostics and laboratory developed tests, reliance upon the collaborative efforts of other parties, the Company's ability to manage its existing cash resources or raise additional cash resources, competition, intellectual property protection and intellectual property rights of others, government regulation particularly with respect to diagnostic products and laboratory developed tests, obtaining or maintaining regulatory approvals, ongoing litigation and investigations and other risks detailed from time to time in the Company's most recent Annual Report on Form 10-K and other documents subsequently filed with or furnished to the Securities and Exchange Commission. These forward-looking statements are based on current information that may change and you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and the Company undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release.


'/>"/>
SOURCE Sequenom, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Texas A&M professor helps develop first high-temp spin-field-effect transistor
2. Rensselaer Polytechnic Institute professor James Lu garners award for research on 3-D computer chips
3. INRS professor Federico Rosei receives a 2010 Friedrich Wilhelm Bessel Research Award
4. Boston College physics professor Willie Padilla receives PECASE award
5. ERC advanced grant for Professor Zandbergens nanolaboratory
6. Professor Leroux From ETH Receives the Debiopharm Life Sciences Award 2010
7. OU professor honored for excellence in chemistry
8. Research from Rensselaer Polytechnic Institute professor offers clues to Alzheimers disease
9. Rensselaer Polytechnic Institute Professor David Corr receives NSF CAREER award
10. Professor Sander van Deventer Appointed to Supervisory Board of AMT
11. Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology'
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... RURO, Inc., a ... of LimitLIS®, its rapidly growing Laboratory Information System. , LimitLIS® version 3 is ... integrity, and provide more customization options. Each of these has been “under the ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Academy of Model Aeronautics ... Aviation Association (UAA), the unifying voice for collegiate aviation education, are launching a ... competition, and success through a STEM-based education platform. , Much like the program ...
(Date:6/22/2017)... ... , ... Building on the success of the inaugural RAADfest last year, RAADfest ... developments in radical life extension. RAADfest combines cutting edge science presented for a lay ... development, making it the largest most comprehensive and inclusive super longevity event in the ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... RegMedNet has produced a Spotlight series on “Cell Therapy ... and perspectives by leading experts on the unique regulatory challenges of stem cell ...
Breaking Biology Technology:
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
Breaking Biology News(10 mins):